Clinical review of chondroitin sulfate in osteoarthritis.
暂无分享,去创建一个
[1] S. Berney. Meta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip , 2008 .
[2] E. D. de Bruin,et al. Chondroitin sulfate as a structure-modifying agent. , 2006, Advances in pharmacology.
[3] E. D. de Bruin,et al. Treatment of knee osteoarthritis with oral chondroitin sulfate. , 2006, Advances in pharmacology.
[4] N. Volpi. Chondroitin sulfate : structure, role and pharmacological activity , 2006 .
[5] E. Vignon,et al. Chondroitins 4 and 6 sulfate in osteoarthritis of the knee: a randomized, controlled trial. , 2005, Arthritis and rheumatism.
[6] E. Vignon,et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. , 2004, Osteoarthritis and cartilage.
[7] G. Verbruggen,et al. Systems to Assess the Progression of Finger Joint Osteoarthritis and the Effects of Disease Modifying Osteoarthritis Drugs , 2002, Clinical Rheumatology.
[8] B. Mazières,et al. Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study. , 2001, The Journal of rheumatology.
[9] D. Felson,et al. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. , 2000, JAMA.
[10] B. Leeb,et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. , 2000, The Journal of rheumatology.
[11] H. Vet,et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. , 1998, Journal of clinical epidemiology.
[12] T. Conrozier. [Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6)]. , 1998, Presse medicale.
[13] J. Dehais,et al. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo. , 1998, Osteoarthritis and cartilage.
[14] E. Thonar,et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. , 1998, Osteoarthritis and cartilage.
[15] G. Verbruggen,et al. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA. , 1998, Osteoarthritis and cartilage.
[16] L. Bucsi,et al. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis. , 1998, Osteoarthritis and cartilage.
[17] G. Verbruggen,et al. Numerical scoring systems for the anatomic evolution of osteoarthritis of the finger joints. , 1996, Arthritis and rheumatism.
[18] J. R. Landis,et al. The measurement of observer agreement for categorical data. , 1977, Biometrics.